Curis Lifesciences IPO description – Curis Lifesciences is engaged in the manufacturing of pharmaceutical products for various global and domestic markets, operating under loan licenses and contract manufacturing agreements, as well as through its brand marketing. As of 31 December 2024, the company serves over 100 corporate clients on a loan license and/or contract manufacturing basis, […]



Source link